312 related articles for article (PubMed ID: 10389761)
21. A novel monoclonal antibody specific for sialylated MUC1 mucin.
Yamamoto M; Bhavanandan VP; Nakamori S; Irimura T
Jpn J Cancer Res; 1996 May; 87(5):488-96. PubMed ID: 8641986
[TBL] [Abstract][Full Text] [Related]
22. MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells.
Fessler SP; Wotkowicz MT; Mahanta SK; Bamdad C
Breast Cancer Res Treat; 2009 Nov; 118(1):113-24. PubMed ID: 19415485
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
[TBL] [Abstract][Full Text] [Related]
24. Antigenic differences between metastatic cells in bone marrow and primary tumours and the anti-MUC1 humoral immune response induced in breast cancer patients.
Croce MV; Isla-Larrain M; Tur R; Rabassa ME; Segal-Eiras A
Clin Exp Metastasis; 2004; 21(2):139-47. PubMed ID: 15168731
[TBL] [Abstract][Full Text] [Related]
25. Cell surface-associated anti-MUC1-derived signal peptide antibodies: implications for cancer diagnostics and therapy.
Kovjazin R; Horn G; Smorodinsky NI; Shapira MY; Carmon L
PLoS One; 2014; 9(1):e85400. PubMed ID: 24416403
[TBL] [Abstract][Full Text] [Related]
26. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein.
Apostolopoulos V; Xing PX; Trapani JA; McKenzie IF
Br J Cancer; 1993 Apr; 67(4):713-20. PubMed ID: 7682431
[TBL] [Abstract][Full Text] [Related]
27. Humanization and epitope mapping of the H23 anti-MUC1 monoclonal antibody reveals a dual epitope specificity.
Mazor Y; Keydar I; Benhar I
Mol Immunol; 2005 Jan; 42(1):55-69. PubMed ID: 15488944
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of the MUC1 gene product in human cancers grown in scid mice.
Schumacher U; Adam E
J Histochem Cytochem; 1998 Jan; 46(1):127-34. PubMed ID: 9405502
[TBL] [Abstract][Full Text] [Related]
29. The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha 2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat.
Takeuchi H; Kato K; Denda-Nagai K; Hanisch FG; Clausen H; Irimura T
J Immunol Methods; 2002 Dec; 270(2):199-209. PubMed ID: 12379325
[TBL] [Abstract][Full Text] [Related]
30. [Soluble expression of peptide containing MUC1/Y-specific epitope in Escherichia coli and preparation of the antibody].
Zhang LX; Li CH; Sun LY; Wang M; Lu HJ
Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):337-42. PubMed ID: 15969018
[TBL] [Abstract][Full Text] [Related]
31. Epithelial mucin-1 (MUC1) expression and MA5 anti-MUC1 monoclonal antibody targeting in multiple myeloma.
Burton J; Mishina D; Cardillo T; Lew K; Rubin A; Goldenberg DM; Gold DV
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3065s-3072s. PubMed ID: 10541345
[TBL] [Abstract][Full Text] [Related]
32. Expression of MUC1 splice variants in benign and malignant ovarian tumours.
Obermair A; Schmid BC; Packer LM; Leodolter S; Birner P; Ward BG; Crandon AJ; McGuckin MA; Zeillinger R
Int J Cancer; 2002 Jul; 100(2):166-71. PubMed ID: 12115565
[TBL] [Abstract][Full Text] [Related]
33. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.
Seko A; Ohkura T; Ideo H; Yamashita K
Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E
Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183
[TBL] [Abstract][Full Text] [Related]
35. MUC1 and cancer.
Taylor-Papadimitriou J; Burchell J; Miles DW; Dalziel M
Biochim Biophys Acta; 1999 Oct; 1455(2-3):301-13. PubMed ID: 10571020
[TBL] [Abstract][Full Text] [Related]
36. The MUC1 oncoprotein as a functional target: immunotoxin binding to alpha/beta junction mediates cell killing.
Rubinstein DB; Karmely M; Pichinuk E; Ziv R; Benhar I; Feng N; Smorodinsky NI; Wreschner DH
Int J Cancer; 2009 Jan; 124(1):46-54. PubMed ID: 18821582
[TBL] [Abstract][Full Text] [Related]
37. MUC1 glycopeptide epitopes predicted by computational glycomics.
Song W; Delyria ES; Chen J; Huang W; Lee JS; Mittendorf EA; Ibrahim N; Radvanyi LG; Li Y; Lu H; Xu H; Shi Y; Wang LX; Ross JA; Rodrigues SP; Almeida IC; Yang X; Qu J; Schocker NS; Michael K; Zhou D
Int J Oncol; 2012 Dec; 41(6):1977-84. PubMed ID: 23023583
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cell-based vaccines in patients with hematological malignancies.
Brugger W; Schneider A; Schammann T; Dill P; Grünebach F; Bühring HJ; Kanz L; Brossart P
Ann N Y Acad Sci; 2001 Jun; 938():359-62; discussion 362-3. PubMed ID: 11458523
[TBL] [Abstract][Full Text] [Related]
39. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.
Bäckström M; Link T; Olson FJ; Karlsson H; Graham R; Picco G; Burchell J; Taylor-Papadimitriou J; Noll T; Hansson GC
Biochem J; 2003 Dec; 376(Pt 3):677-86. PubMed ID: 12950230
[TBL] [Abstract][Full Text] [Related]
40. Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies.
Guillaume T; Dehame V; Chevallier P; Peterlin P; Garnier A; Grégoire M; Pichinuk E; Rubinstein DB; Wreschner DH
Exp Hematol; 2019 Feb; 70():97-108. PubMed ID: 30593830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
